## Gold Standard Treatment for Opioid Use Disorder **Key Point:** Methadone maintenance therapy is the gold standard and most effective pharmacological treatment for opioid use disorder, with the strongest evidence base for long-term abstinence and reduced illicit opioid use. ### Why Methadone? **High-Yield:** Methadone is a synthetic full mu-opioid agonist that: - Prevents withdrawal symptoms - Blocks euphoric effects of other opioids (cross-tolerance) - Has a long half-life (24–36 hours), allowing once-daily dosing - Achieves high treatment retention rates (60–90%) - Reduces illicit opioid use by 50–60% in compliant patients ### Comparative Efficacy | Treatment | Mechanism | Efficacy | Retention | Key Limitation | | --- | --- | --- | --- | --- | | **Methadone** | Full mu-agonist | Highest | 60–90% | Overdose risk, requires daily clinic visits | | **Buprenorphine** | Partial mu-agonist | High | 40–70% | Lower ceiling effect, less effective for heavy users | | **Naltrexone** | Mu-antagonist | Moderate | 10–30% | Very poor retention, requires high motivation | | **Clonidine** | Alpha-2 agonist | Symptomatic only | N/A | Does not prevent craving or relapse | **Clinical Pearl:** Buprenorphine is increasingly preferred in office-based settings due to lower overdose risk and flexible dosing, but methadone remains superior for severe opioid use disorder and has the strongest evidence base. **Warning:** Naltrexone, despite being opioid-free, has the poorest retention rates (10–30%) because it does not address cravings and requires high patient motivation. Clonidine only treats acute withdrawal symptoms and is never used as monotherapy for maintenance. [cite:Harrison 21e Ch 395]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.